NF-κB
NF-κB is a family of conserved and ubiquitous transcription factors that involved in various biological processes including immunity, inflammation, cell growth, differentiation and apoptosis. It is associated with cancer, chronic inflammation and arthritis etc.
Products Related to NF-κB(335)
- GC84264TLR4/NF-κB-IN-1CAS: 3050836-94-4Purity: >99.50%
TLR4/NF-κB-IN-1 (Compound 7x) is an orally available inhibitor that specifically targets the TLR4/NF-κB signaling pathway, offering anti-inflammatory effects and the ability to cross the blood-brain barrier.
- GC84265TLR8 antagonist-1CAS: 1111460-83-3Purity: >99.50%
TLR8 antagonist-1 (Compound 10) is a selective TLR8 antagonist.
- GC84273TNF-α (31-45), human TFAPurity: >99.00%
TNF-α (31-45), human TFA is a potent NF-kB pathway activator.
- GC84278Tofacitinib- 13 C 3 , 15 NPurity: >99.50%
Tofacitinib - 13 C 3, 15 N (Tasocitinib- 13 C 3, 15 N; CP-690550- 13 C 3, 15 N) is the 15 N, 13 C-labeled Tofacitinib.
- GC84591Anti-Mouse RANKL/CD254 Antibody (IK22/5)Purity: >99.00%
Anti-Mouse RANKL/CD254 Antibody (IK22/5) is an anti-mouse RANKL/CD254 IgG2a monoclonal antibody.
- GC84674IKKγ NBD Inhibitory Peptide TFAPurity: >98.50%
IKKγ NBD Inhibitory Peptide TFA is a highly specific inhibitor NF-κB inhibitor.
- GC84770Sappanone ACAS: 102067-84-5Purity: >99.50%
Sappanone A is an orally active homoisoflavone found in sappan L.
- GC84789(+)-Magnoflorine iodideCAS: 4277-43-4Purity: >99.50%
(+)-Magnoflorine (α-Magnoflorine) iodide is an orally active aporphine alkaloid with multiple biological activities.
- GC84872NF-κB-IN-4CAS: 3033258-60-2Purity: >98.50%
NF-κB-IN-4 (compound 17) is a potent NF-κB pathway inhibitor with blood brain barrier (BBB) permeability.
- GC10130Chicago Sky Blue 6BCAS: 2610-05-1Purity: >97.50%
Chicago Sky Blue 6B is a counterstain for background autofluorescence in fluorescence and immunofluorescence histochemistry. Chicago Sky Blue 6B is a potent competitive inhibitor of vesicular glutamate transporter 1 (VGLUT1) with an IC 50 of 3μM.
- GC10345Bay 11-7085CAS: 196309-76-9Purity: >99.00%
Bay 11-7085 is an inhibitor of NF-κB activation and phosphorylation of IκBα with an IC 50 value of 10μM for IκBα.
- GC10474Laquinimod (ABR-215062)CAS: 248281-84-7Purity: >98.00%
Laquinimod (ABR-215062) (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system.
- GC10480Betulinic acidCAS: 472-15-1Purity: >98.00%
Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC 50 value of 5 μM.
- GC10519Ethacrynic acid - d5CAS: 1330052-59-9Purity: >98.00%
Used as an internal standard for GC- or LC-mass spectrometry
- GC1082111-keto-β-Boswellic AcidCAS: 17019-92-0Purity: >99.50%
11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production.
- GC11736NF-κB Activation Inhibitor IIICAS: 380623-76-7Purity: >98.00%
NF-κB Activation Inhibitor III is a potent NF-kB inhibitor that targets downstream of MAPK p38 activation. NF-κB Activation Inhibitor III inhibits TNF-α-induced MMP-9 upregulation. NF-κB Activation Inhibitor III can be used for the research of chemotherapies targeting TNF-α-mediated tumor invasion and metastasis .
- GC11751QNZ (EVP4593)CAS: 545380-34-5Purity: >98.00%
QNZ (EVP4593) is a highly potent and selective inhibitor of the nuclear factor κB (NF-κB) signaling pathway with an IC 50 value of 11nM and has anti-inflammatory effects.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC84086 | SjDX5-271 | 2767993-76-8 | >98.50% | |
SjDX5-271 is a small 3 kDa peptide. | ||||
| GC84117 | SPA0355 | 1251839-15-2 | >99.50% | |
SPA0355 is a thiourea derivative that has antioxidant and anti-inflammatory properties. | ||||
| GC84264 | TLR4/NF-κB-IN-1 | 3050836-94-4 | >99.50% | |
TLR4/NF-κB-IN-1 (Compound 7x) is an orally available inhibitor that specifically targets the TLR4/NF-κB signaling pathway, offering anti-inflammatory effects and the ability to cross the blood-brain barrier. | ||||
| GC84265 | TLR8 antagonist-1 | 1111460-83-3 | >99.50% | |
TLR8 antagonist-1 (Compound 10) is a selective TLR8 antagonist. | ||||
| GC84273 | TNF-α (31-45), human TFA | - | >99.00% | |
TNF-α (31-45), human TFA is a potent NF-kB pathway activator. | ||||
| GC84278 | Tofacitinib- 13 C 3 , 15 N | - | >99.50% | |
Tofacitinib - 13 C 3, 15 N (Tasocitinib- 13 C 3, 15 N; CP-690550- 13 C 3, 15 N) is the 15 N, 13 C-labeled Tofacitinib. | ||||
| GC84309 | Triptolide-d 3 | - | >91.50% | |
Triptolide-d 3 is the deuterium labeled Triptolide. | ||||
| GC84591 | Anti-Mouse RANKL/CD254 Antibody (IK22/5) | - | >99.00% | |
Anti-Mouse RANKL/CD254 Antibody (IK22/5) is an anti-mouse RANKL/CD254 IgG2a monoclonal antibody. | ||||
| GC84674 | IKKγ NBD Inhibitory Peptide TFA | - | >98.50% | |
IKKγ NBD Inhibitory Peptide TFA is a highly specific inhibitor NF-κB inhibitor. | ||||
| GC84770 | Sappanone A | 102067-84-5 | >99.50% | |
Sappanone A is an orally active homoisoflavone found in sappan L. | ||||
| GC84789 | (+)-Magnoflorine iodide | 4277-43-4 | >99.50% | |
(+)-Magnoflorine (α-Magnoflorine) iodide is an orally active aporphine alkaloid with multiple biological activities. | ||||
| GC84872 | NF-κB-IN-4 | 3033258-60-2 | >98.50% | |
NF-κB-IN-4 (compound 17) is a potent NF-κB pathway inhibitor with blood brain barrier (BBB) permeability. | ||||
| GB57663 | Chitin | 1398-61-4 | - | |
Chitin is a variety of sugars extracted from the shells of marine crustaceans and is widely found in shrimp and crabs in nature. | ||||
| GC10130 | Chicago Sky Blue 6B | 2610-05-1 | >97.50% | |
Chicago Sky Blue 6B is a counterstain for background autofluorescence in fluorescence and immunofluorescence histochemistry. Chicago Sky Blue 6B is a potent competitive inhibitor of vesicular glutamate transporter 1 (VGLUT1) with an IC 50 of 3μM. | ||||
| GC10345 | Bay 11-7085 | 196309-76-9 | >99.00% | |
Bay 11-7085 is an inhibitor of NF-κB activation and phosphorylation of IκBα with an IC 50 value of 10μM for IκBα. | ||||
| GC10474 | Laquinimod (ABR-215062) | 248281-84-7 | >98.00% | |
Laquinimod (ABR-215062) (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. | ||||
| GC10480 | Betulinic acid | 472-15-1 | >98.00% | |
Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC 50 value of 5 μM. | ||||
| GC10519 | Ethacrynic acid - d5 | 1330052-59-9 | >98.00% | |
Used as an internal standard for GC- or LC-mass spectrometry | ||||
| GC10821 | 11-keto-β-Boswellic Acid | 17019-92-0 | >99.50% | |
11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production. | ||||
| GC11736 | NF-κB Activation Inhibitor III | 380623-76-7 | >98.00% | |
NF-κB Activation Inhibitor III is a potent NF-kB inhibitor that targets downstream of MAPK p38 activation. NF-κB Activation Inhibitor III inhibits TNF-α-induced MMP-9 upregulation. NF-κB Activation Inhibitor III can be used for the research of chemotherapies targeting TNF-α-mediated tumor invasion and metastasis . | ||||
| GC11751 | QNZ (EVP4593) | 545380-34-5 | >98.00% | |
QNZ (EVP4593) is a highly potent and selective inhibitor of the nuclear factor κB (NF-κB) signaling pathway with an IC 50 value of 11nM and has anti-inflammatory effects. | ||||
| GC12114 | Oxaprozin | 21256-18-8 | >99.50% | |
COX inhibitor | ||||
| GC12532 | CHPG | 170846-74-9 | >98.00% | |
CHPG is a selective metabotropic glutamate receptor 5 (mGlu5) agonist. | ||||
| GC13030 | (R)-(-)-Ibuprofen | 51146-57-7 | >99.50% | |
Inhibitor of Cox-1 and Cox-2 | ||||
